נולוג'יקס 250 מ"ג

Country: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

BELATACEPT 25 MG/ML

Boleh didapati daripada:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

Kod ATC:

L04AA28

Borang farmaseutikal:

POWDER FOR CONCENTRATE FOR INFUSION

Laluan pentadbiran:

I.V

Dikeluarkan oleh:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Kumpulan terapeutik:

BELATACEPT

Tanda-tanda terapeutik:

Nulojix, in combination with corticosteroids and mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. It is recommended to add an interleukin (IL)-2 receptor antagonist for induction therapy to this belatacept-based regimen

Tarikh kebenaran:

2012-08-01